Overall rank by patents
#655
Across all tracked assignees
USPTO PatentsView assignee record - 685 granted patents across 94 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).
The verdict
The holds 685 US patents across 94 technology areas, rank #655 of 50,000 tracked assignees.
The Brigham And Women's Hospital, Inc. has been granted 685 US utility patents between 2015 and 2025, placing The Brigham And Women's Hospital, Inc. at rank #655 across all assignees tracked by PlainPatent. This portfolio spans 94 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.3 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a US Corporation, The Brigham And Women's Hospital, Inc. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, The sits between Saturn Licensing Llc (689 patents, rank #651) and M.s. Technologies, L.l.c. (681 patents, rank #659) - the closest US assignees by grant volume. The composite Innovation Score of 64.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 388 grants, compared with 297 in the 2015–2019 window, a +31% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. The Brigham And Women's Hospital, Inc.'s 17.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 94 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark The Brigham And Women's Hospital, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
SATURN LICENSING LLC
689 patents
The Research Foundation for The State University of New York
688 patents
EVONIK DEGUSSA GMBH
686 patents
GM Cruise Holdings LLC
685 patents
Yale University
685 patents
The Brigham and Women's Hospital, Inc.
685 patents
TIANMA MICROELECTRONICS CO., LTD.
684 patents
BAYER HEALTHCARE LLC
681 patents
M.S. Technologies, L.L.C.
681 patents
What this shows The holds 685 patents at rank #655, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #655 in granted patent volume.
Other assignees with the most granted patents in The's primary technology class.
The's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
65 Top 2% higher than 98% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 39 | 5.7% |
| 2016 | 62 | 9.1% |
| 2017 | 59 | 8.6% |
| 2018 | 58 | 8.5% |
| 2019 | 79 | 11.5% |
| 2020 | 66 | 9.6% |
| 2021 | 68 | 9.9% |
| 2022 | 70 | 10.2% |
| 2023 | 71 | 10.4% |
| 2024 | 70 | 10.2% |
| 2025 | 43 | 6.3% |
Top 15 of 94 technology areas
Overall rank by patents
#655
Across all tracked assignees
64.5 out of 100
How to use this portfolio
The's 685 grants land it in the top 2% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.